Shugang Cao Jing Du Sidi Pan Juanjuan Zhang Si Xu Ling Wei Yanghua Tian
10.3389/fimmu.2023.1164181
Front Immunol
2023 May 8;14:1164181.
efficacy glial fibrillary acidic protein astrocytopathy ofatumumab rituximab safety
CC BY
https://pubmed.ncbi.nlm.nih.gov/37223100/
Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Autoimmune Diseases / therapy
Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Autoimmune Diseases / therapy Case Reports Adult Female Glial Fibrillary Acidic Protein Humans Hypersensitivity Immunosuppressive Agents Rituximab / therapeutic use Antibodies, Monoclonal, Humanized Glial Fibrillary Acidic Protein Immunosuppressive Agents ofatumumab Rituximab
PMC10200986
37223100
Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy
2023